Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;61(1):157-165.
doi: 10.20471/acc.2022.61.01.21.

NONMELANOMA SKIN CANCER IN A HEART TRANSPLANT PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

Affiliations
Review

NONMELANOMA SKIN CANCER IN A HEART TRANSPLANT PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

Lorena Karla Rudež et al. Acta Clin Croat. 2022 Mar.

Abstract

Nonmelanoma skin cancers (NMSC) are the most common malignancies in solid organ transplant recipients. The most common types of skin cancer in these patients are squamous cell carcinoma (SCC), followed by basal cell carcinoma. In immunosuppressed patients, specifically patients after solid organ transplantation, these carcinomas tend to be more aggressive and have a much higher incidence of metastasizing compared to general population. We present a case of a patient who developed numerous SCCs after successful heart transplantation. SCCs which occurred in our patient were mostly treated surgically. However, the lesion on the scalp relapsed after it had been treated surgically three times and therefore superficial x-ray radiation therapy was administered due to its localization and extensive size. In the next year, five more new SCCs occurred throughout the patient's body and all of them were removed surgically. Soon afterwards, the patient died from adenocarcinoma of the colon which rapidly progressed and metastasized.

Keywords: Heart transplantation; Immunosuppressants; Radiotherapy; Skin cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Histopathologic analysis of biopsies obtained from three different locations confirmed the diagnosis of squamous cell carcinoma.
Fig. 2
Fig. 2
The affected area four weeks of radiotherapy completion.
Fig. 3
Fig. 3
The primary affected area at six-month follow up.

Similar articles

References

    1. Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg. 2012. October;38(10):1622–30. 10.1111/j.1524-4725.2012.02520.x - DOI - PubMed
    1. De Rosa N, Paddon VL, Liu Z, Glanville AR, Parsi K. Nonmelanoma skin cancer frequency and risk factors in Australian heart and lung transplant recipients. JAMA Dermatol. 2019. June 1;155(6):716–9. 10.1001/jamadermatol.2018.4789 - DOI - PMC - PubMed
    1. Albayati A, Ozkan B, Eyuboglu AA, Uysal AC, Markal Ertas N, Haberal M. Nonmelanoma skin cancers in solid-organ transplant recipients: a single center experience. Exp Clin Transplant. 2018. March;16 Suppl 1:95–100. 10.6002/ect.TOND-TDTD2017.O36 - DOI - PubMed
    1. Van Keer J, Droogné W, Van Cleemput J, Vörös G, Rega F, Meyns B, et al. Cancer after heart transplantation: a 25-year single-center perspective. Transplant Proc. 2016. August;48(6):2172–7. 10.1016/j.transproceed.2016.03.037 - DOI - PubMed
    1. Alam M, Brown RN, Silber DH, Mullen GM, Feldman DS, Oren RM, et al. Increased incidence and mortality associated with skin cancers after cardiac transplant. Am J Transplant. 2011. July;11(7):1488–97. 10.1111/j.1600-6143.2011.03598.x - DOI - PubMed

MeSH terms